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Abstract
Purpose. 
Although there have been many studies on polycystic liver disease (PCLD), most have not considered 
the effectiveness of computed tomography volumetry for liver resection as part of reduction surgery. 
In this study, we report the techniques used for liver resection in reduction surgery for PCLD and 
describe the theoretical basis. 
Methods. 
We performed clinical and imaging investigations in five patients with PCLD whose chief complaints 
were abdominal distention and early satiety. 
Results. 
The average plasma indocyanine green retention at 15 min (ICG R15), which indicates hepatic 
functional reserve, was 11.3 ± 6.7%, indicating moderate liver damage. The average galactosyl 
human serum albumin uptake during single photon emission tomography uptake for assessing 
asialoscintigraphy was 50.6% ± 17.8%, indicating slightly decreased uptake. The disease was present 
in both lobes of the liver in all patients except one, in whom PCLD was localized in the left lobe. 
Because multiple cysts were present in the hepatic radial margin, we only resected cysts without the 
surrounding parenchyma when possible. The cyst walls were comparatively tough and firm. Because 
Glisson’s capsule was present between the cysts, resection was performed with double or triple 
ligation with transfixing sutures to prevent suture failure and postoperative biliary leakage. Only 
one patient reported symptom recurrence because of enlargement of cyst remnants. 
The average preoperative and postoperative total liver volumes were 4644 ± 1813 cm3 and 2698
± 1615 cm3, respectively, indicating a significant decrease (p < 0.01). The average preoperative 
cyst volume was 3765 ± 1780 cm3, which decreased to 1894 ± 1546 cm3 after surgery, indicating 
a significant 35% decrease in cyst volume (p < 0.01). The average preoperative and postoperative 
noncystic volumes were 880 ± 80 cm3 and 805 ± 173 cm3, respectively, indicating no significant loss 
of liver parenchyma. 
Conclusion. 
The goal of liver resection in PCLD is bulk reduction to alleviate abdominal distention and early 
satiety. All patients in this study were alive at the time of publication, indicating that the surgery 
allows patients to survive beyond a few years.
Key term: polycystic liver disease, reduction surgery, liver regeneration, computed tomography 
volumetry
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Introduction 
　Adult polycystic liver disease (PCLD) is a benign 
disease that causes the liver to swell gradually, 
resulting in increasing feelings of distention 
and abdominal pain. In addition, patients often 
eventually present with cyst infection, cyst 
rupture, portal hypertension, and other conditions
〔1〕.
　Numerous treatments have been used for 
PCLD. Approaches in internal medicine involve 
cyst aspiration and injections with ethanolamine 
oleate and other drugs〔2〕. In addition, surgical 
treatment options include liver resection, cyst 
fenestration, and liver transplantation〔3, 4〕. Liver 
transplantation is considered a radical treatment, 
but most cases in Japan involve living donor 
transplantation. Because family members often 
have the same disease, the number of potential 
donors is limited, making liver transplantation 
more difficult than other transplantations. Recent 
studies have focused on laparoscopic liver resection.
　Although there are many studies on PCLD, few 
have reported on the significance of liver resection 
using computed tomography (CT) volumetry or 
have provided details of the surgical technique used
〔5〕. In this study, we report the techniques used for 
liver resection in reduction surgery for PCLD and 
outline the theory behind these techniques. 
Patients and Methods　
　We enrolled five patients with PCLD who 
underwent liver resection at Yamagata University 
Hospital First Department of Surgery between 
2002 and 2012. We recorded their age, sex, liver 
function, liver reserve function as indicated by 
indocyanine green retention at 15 min (ICG R15), 
and asialoscintigraphy findings. PCLD was 
described using Gigot’s classification as follows〔6〕. 
Type I patients had less than 10 cysts measuring 
≥10 cm. Type II patients had medium-sized cysts 
distributed diffusely in the liver, with large areas 
of normal residual liver parenchyma. Type III 
patients had diffuse distribution of cysts with 
very little normal residual liver parenchyma. We 
obtained a large biochemical sample of intracystic 
fluid from one patient.
　The method used for asialoscintigraphy at our 
department involves the injection of 185 mBq of 
technetium-99m-diethylenetriaminepentaacetic 
acid-galactosyl human serum albumin (99mTc-
GSA) via an ulnar vein, followed by measurement 
of the uptake from 12.5 min to 17.5 min after 
in ject ion.  Final ly ,  the  value  produced by 
asialoscintigraphy is measured using single photon 
emission computed tomography (SPECT) 〔7〕.
　Liver resection for the reduction of hepatic cysts 
was performed to alleviate the chief complaints of 
abdominal distention and early satiety and allow 
patients to return to a normal life. Therefore, 
rather than resecting all cysts, we resected only 
those in select regions of the liver where several 
cysts were concentrated with little or no normal 
residual liver parenchyma. At the same time, we 
left areas of normal liver parenchyma untouched.
　Because the cyst walls were comparatively 
tough, we used Rochester Pean forceps and Kelly 
forceps (Leibinger, Germany) to open them, but 
considerable pressure was required to pierce the 
walls. Normally, we use an electrosurgical knife to 
dissect cyst walls.
　Multiple cysts were present in the hepatic radial 
margin, and Glisson’s capsule was present between 
the cysts. Therefore, we performed resection with 
double or triple ligation using transfixing sutures, 
with 5 to 10 mm between the ligations and the 
margin to prevent suture failure and loosening and 
consequent postoperative biliary leakage.
　CT volumetry was conducted by tracing all 
CT images, calculating the cystic and noncystic 
regions, and calculating the total of all the 
sections. 
Results
　The average age of the patients was 55.6 years 
(range, 51-68 years) and the ratio of males to 
females was 2:3 (Table 1). The chief complaints 
were epigastric distention and pain. Three patients 
presented with concurrent polycystic kidney 
disease (PCKD).
　The average ICG R15 was used as an indicator 
of liver reserve function and was 11.3 ± 6.7%, 
indicating moderate liver damage. However, the 
polycystic liver disease
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average 99mTc-GSA SPECT uptake was 50.6% ±
17.8%, indicating a slight decrease (Table 1). 
　PCLD was located in both lobes (Fig. 2 a-c) 
peripherally, rather than in the center of the liver 
(Table 1).
　Biochemical tests were performed on cyst fluid 
in all patients except one, 
in  whom i t  was  l o ca t ed 
mainly in the left lobe (Fig. 
1 a, b). According to Gigot’s 
classification, there was one 
Type I and Type II patient 
each and were three Type III 
patients (Table 1).
　 W e  u s e d  a  v a r i e t y  o f 
surgical techniques, as shown 
in Table 1. However, most 
surgeries were performed 
Fig. 1a.
Dominant left lobe resection in 
a Type I patient according to 
Gigot’s classification (Table 1; 
Patient 4) 
Fig. 1b.
Disappearance of epigastric 
pain after surgery 
Table 1. Patient characteristics
Patient Age Sex Chief 
complaint
PCLD ICG 
R15 
GSA Gigot’s 
class
Location Surgical 
technique(s)
Complication(s) Prognosis
1 47 F Abdominal 
distention
Yes 8 % 62 Type II Both lobes Lateral 
segmentectomy
Posterior 
segmentectomy 
Slight bile 
leakage
Good
2 51 M Abdominal 
distention
Yes 11 43 Type III Both lobes S7, 8 resection
S4, 2, 6 fenestration
Slight bile 
leakage
Good
3 52 F Epigastric 
distention
Yes 22 34 Type III Both lobes Lateral 
segmentectomy
S6 partial resection
None Cyst 
enlargement in 
remnant liver
4 60 F Abdominal 
pain
No 4 76 Type I Mainly L. 
lobe
L. lobe resection,
S7 fenestration
Hemorrhage 
into drain
Good
5 68 M Epigastric 
distention
No 11 38 Type III Both lobes S3, 5, 6 partial 
resection
Bile leakage Bile leakage 
ceased after 2.5 
years
Fig. 2a.
Type III patient according to 
Gigot’s classification (Table 1; 
Patient 5) 
Fig. 2b.
S5 and S6 resection was done for 
Type III patient. 
Fig. 2c. 
An intraoperative view showing 
pericystic infection proximal 
to S6 resection revealed that 
the fluid within the cysts was 
bile. The patient experienced 
prolonged postoperative bile 
leakage. 
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collected from 34 locations in a single participant 
(Fig.3 case). All cyst fluid samples had a total 
bilirubin count of <0.1 mg/dL. The average 
carcinoembryonic antigen (CEA) level was 29.8 ±
73.3 ng/mL (range, 0.4-357.6), and 25 cysts (73.5%) 
had CEA values of ≥3 ng/mL. The carbohydrate 
antigen 19-9 (CA19-9) level was ≥9999 U/L in all 
samples.
　Bile was present inside the peripheral hepatic 
cysts of two patients. One of the patients with 
cysts containing bile required drain placement 
for 2 years and 6 months. In another patient, we 
identified areas of bile flow by observing Glisson’s 
capsule between many of the cysts. We sutured 
these areas using PDS®II 4-0 sutures (Ethicon, 
Japan) and observed no postoperative bile leakage. 
　Patients were discharged from the hospital by an 
average of 33.2 ± 8.8 days after surgery (range, 24-
44 days). The abdominal symptoms disappeared in 
all patients. In patient 3, gastric distention due to 
PCLD was relieved and nutritional intake improved 
after resecting the left lateral segment of the liver. 
CT performed on an outpatient basis indicated no 
enlargement in the hepatic parenchyma and few 
cysts (Fig. 4 a-e). Enlargement of hepatic cysts was 
observed in the remnant liver in only one of the 
five patients.
　 I n  p a t i e n t  2 ,  p r e o p e r a t i v e  a s p a r t a t e 
aminotransferase and alanine transaminase were 
elevated at 72 U/L and 63 U/L, respectively, but 
they returned to normal levels (24 U/L and 23 U/
L, respectively) after surgery. Currently, 4 of the 5 
patients have no symptoms and are being observed 
as outpatients. The cysts in the right lobe of the 
remnant liver have enlarged in the patient who 
underwent lateral segment and S6 resection.
　We performed CT volumetry in all patients. 
The average preoperative and postoperative total 
hepatic volumes were 4644 ± 1813 cm3 and 2698
± 1615 cm3, respectively, indicating a significant 
Fig. 3a．
Resections of the lateral segment 
and posterior segment were done 
for Type II patient according to 
Gigot’s classification (Table 1; 
Patient 1). 
Fig. 3d．
Because of the large number of preoperative cysts, 
resection was performed mainly in the posterior 
and the lateral segments. 
Fig. 3b. 
A decrease in postoperative 
cyst volume and an increase in 
noncystic liver parenchyma 
Fig. 3e. 
The main cysts were resected and the central 
portion of the liver, where there were few cysts, 
was preserved.
Fig. 3c．
Preoperative asialoscintigraphy 
is useful for determining the 
scope of liver resection to 
preserve the functional red 
areas.
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decrease in total hepatic volume (p < 0.01) (Table 2). 
The average preoperative cystic volume was 3765 
± 1780 cm3, decreasing to 1894 ± 1546 cm3 after 
surgery. The average decrease was approximately 
35%, and cystic volume significantly decreased 
by up to 49.7% of the preoperative volume (p < 
0.01). The average preoperative and postoperative 
noncystic volumes were 880 ± 80 cm3 and 805 ±
173 cm3, respectively, indicating that there was no 
significant loss of parenchymal volume.
　In all patients, the chief preoperative complaints 
of abdominal distention and early satiety were 
alleviated. The patients are able to lead comfortable 
lives because of increased appetite and improved 
nutrition.
Table 2. Changes in liver volume on computed tomography (cm3)
Patient Preop. total liver vol. Postop. total liver vol. Preop. cyst vol. Postop. cyst vol. Preop. Noncyst vol. Postop. noncyst vol.
1 3918 cm3 1204 3167 459 752 746
2 7307 4610 6352 3582 955 1028
3 3985 3180 3046 2255 938 925
4 2542 852 1663 115 879 737
5 5472 3646 4597 3059 875 587
Average 4644 ± 1813 2698 ± 1615 3765 ± 1780 1894 ± 1546 880 ± 80 805 ± 173
Decrease rate of cystic volume: (preoperative cyst volume-postoperative cyst volume)/preoperative cyst volume = (3765-
1894)/3765 = 49.7%
Fig. 4a.
Resection of the lateral segment 
with large numbers of cysts in 
a Type III patient according to 
Gigot’s classification (Table 1; 
Patient 3)
Fig. 4d. 
Because the cyst walls are tough, the Pean fracture 
method is used for resection. Because there is crushed 
liver parenchyma and Glisson’s capsule between the 
cyst walls, it is important to use transfixing sutures to 
prevent postoperative hemorrhage and bile leakage. 
Fig. 4b. 
Same computed tomography 
slice obtained after surgery. 
Gastric pressure and other 
symptoms have disappeared. 
Fig. 4e. 
Drainage tube at the liver resection margin
Total bilirubin in the drainage fluid collected 
after surgery was measured, and the tube 
was removed when the level was comparable 
to serum levels. 
Fig. 4c. 
Findings during laparotomy 
indicate cysts on the lateral 
segment and in S6. 
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Discussion　 
　PCLD is divided into childhood and adult types. 
The frequency of the adult type is reported to be 
0.05% to 0.13%〔8, 9〕. The incidence is 4 to 5 times 
higher in women than in men．PCLD is often 
complicated by autosomal dominant polycystic 
kidney disease〔10〕.However, PCLD is not observed 
in patients with autosomal dominant polycystic 
liver disease〔11〕. The leading cause of death in 
PCLD is kidney failure caused by advanced disease.
　When cysts enlarge, the patient experiences a 
feeling of pressure that can be concentrated in 
the gastric region after meals〔12〕. PCLD can be 
complicated by cyst infection, which is difficult 
to treat〔13〕. It has been reported that positron 
emission tomography-computed tomography 
is useful for the diagnosis of cyst infection〔14〕 
and that high serum CA19-9 levels are useful 
indicators〔15〕. Other complications include 
cholangiocarcinoma, cyst rupture, and massive 
ascites due to inferior vena cava occlusion〔14〕.
　Medical approaches include shrinkage of the 
cysts via the administration of molecular targeting 
drugs and lanreotide (Somatuline®)〔16〕. It is 
believed that the mammalian target of rapamycin 
(mTOR) inhibitor sirolimus is effective; however, 
its use is not yet established〔17〕. Transcatheter 
arterial embolization (TAE) is also reported to 
be effective for patients who are not suitable for 
surgical treatment〔18〕.
　Because gene therapy is not currently available, 
the only radical approach is liver transplantation
〔19-21〕. In Europe, the 5-year survival rate in 584 
liver transplantations was reportedly 84%〔22〕.In 
Japan, where living donor liver transplantation 
is practiced, donors are usually family members. 
However, it is highly likely that nonspouse 
relatives have the same genetic makeup〔23〕.PCLD 
patients often have associated PCKD, making 
kidney failure a common cause of death. Therefore, 
only hepatorenal transplantation, rather than 
liver transplantation alone, can rightfully be 
called a true radical therapy〔24, 25〕. Therefore, liver 
resection with cyst fenestration has been proposed 
as a therapeutic approach for PCLD, primarily 
because it is a less invasive alternative to liver 
transplantation and does not require postoperative 
immunosuppression〔26-30〕. A French group reported 
that in patients with PCLD without end-stage renal 
failure in whom noncystic hepatic parenchyma 
occupies ≥30% of the total liver, resection is 
preferred over transplantation〔31〕. The Mayo 
group has also reported that the 5-year survival 
rate for liver resection with cyst fenestration is 
92%, while that for liver transplantation is 60%
〔4〕. Recently, fenestration has been performed 
laparoscopically〔11, 32〕. On the basis of Gigot’s 
classification, type I patients are considered 
good candidates for laparoscopic fenestration〔6〕.
In addition, extended fenestration is considered 
effective for patients with type II disease, although 
long-term observation is recommended. However, 
patients with type III disease have poor prognoses 
and are contraindicated. 
　During liver resection in our patients with 
PCLD, we noted thin sections of liver parenchyma 
extending to the edges of the cyst surfaces. The 
resection line should not include this thin brown 
extension of the liver parenchyma. Resection only 
up to the white cyst walls is important to prevent 
postoperative bile leakage. 
　In conventional liver resection, the Pean fracture 
method is used to resect the liver parenchyma. 
Then, the liver parenchyma is fragmented using 
a Cavitron®ultrasonic surgical aspirator (CUSA) 
and the remaining blood vessels and Glisson’s 
capsule are ligated. However, because the resection 
margin in most PCLD patients is at the tough cyst 
walls, it is difficult to use a CUSA because the liver 
parenchyma remains between the cysts. In liver 
resection, this margin is normally sutured once, 
but this is risky in PCLD patients because the 
sutures may break or loosen because of the tough 
cyst walls. Also, the presence of Glisson’s capsules 
between the cyst walls increases the concern of bile 
leakage after surgery. Therefore, we performed 
double suturing with nonabsorbable transfixing 
sutures (Ticron, Covidien, Tokyo), maintaining 
a distance of 5-10 mm between each ligation and 
the resected area to prevent subsequent tearing or 
loosening. It is important to prevent bile leakage 
from the liver parenchyma and Glisson’s capsule 
polycystic liver disease
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between the cyst walls. It has been reported 
that bile duct stents implanted using endoscopic 
retrograde cholangiopancreatography (ERCP) are 
effective for bile leakage after liver resection for 
PCLD〔33〕. 
　Our approach to PCLD is to resect areas of 
the liver with high concentrations of cysts and 
fenestrate the larger remaining cysts. In our 
investigation, we found that both total liver 
volume and cyst volume decreased significantly 
after liver resection. In addition, there was no 
significant difference between the preoperative 
and postoperative volumes of relatively unaffected 
noncystic liver parenchyma. Therefore, despite 
the presence of cysts that affect liver function 
in PCLD patients, resection of the main cyst-
containing areas can preserve normal noncystic 
liver parenchyma by preferentially reducing cyst 
volume. 
　Reduction of cyst bulk caused the disappearance 
of the chief complaints in all patients and allowed 
them to lead normal lives. The goal of liver 
resection in PCLD is bulk reduction to alleviate 
abdominal bloating and early satiety. All patients 
in this study were alive at the time of publication, 
indicating that the surgery allows patients to 
survive beyond a few years. 
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